Funding Round
Neuralink announces $500M Series F at $12B valuation — largest BCI funding round ever
Bloomberg4/27/2026·04/27/26🌐 USA
Summary
Neuralink's record-breaking $500M Series F, securing a $12B valuation, signals significant investor confidence in its brain-computer interface technology. This capital infusion will likely accelerate R&D and clinical trial progress, impacting the BCI landscape for researchers, investors, and clinicians alike.
Why it matters
A $12B valuation for a pre-revenue neurotechnology company is unprecedented and will redefine valuation benchmarks for the entire neurotech sector. The sovereign wealth fund participation signals global geopolitical interest in BCI leadership and will intensify competitive investment in Neuralink's Chinese and European rivals.
#BCI#Industry#Neural Interfaces#USA#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in